Back to search
Fistulizing Crohns Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fistulizing Crohns Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Fistulizing Crohns Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Perianal fistulizing Crohn's disease (pCD) represents a severe phenotype of Crohn's disease, affecting approximately 20-30% of patients and resulting in chronic…
This is a double-blind, randomized, placebo-controlled, sequential cohort, ascending dose clinical trial to evaluate the safety and determine the efficacy of as…
This study will compare the efficacy and safety of TDM (therapeutic drug monitoring)-based infliximab (CT-P13, RemsimaTM) intravenous therapy compared with the…
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkuma…
In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The…